Search

Tandem Diabetes Care Inc

Geschlossen

BrancheGesundheitswesen

17.17 0.23

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

16.95

Max

17.25

Schlüsselkennzahlen

By Trading Economics

Einkommen

-20M

-20M

Verkäufe

-43M

247M

EPS

-0.3

Gewinnspanne

-8.249

Angestellte

2,500

EBITDA

-25M

-14M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+68.75% upside

Dividenden

By Acuity

Nächstes Ergebnis

6. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-121M

1.2B

Vorheriger Eröffnungskurs

16.94

Vorheriger Schlusskurs

17.17

Nachrichtenstimmung

By Acuity

50%

50%

146 / 340 Ranking in Healthcare

Tandem Diabetes Care Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Juli 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21. Juli 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20. Juli 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Peer-Vergleich

Kursveränderung

Tandem Diabetes Care Inc Prognose

Kursziel

By TipRanks

68.75% Vorteil

12-Monats-Prognose

Durchschnitt 28.89 USD  68.75%

Hoch 55 USD

Tief 15.5 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Tandem Diabetes Care Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

15 ratings

9

Buy

6

Halten

0

Sell

Stimmung

By Acuity

146 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat